APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Immunodeficiency Virus Type-1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Immunodeficiency Virus Type-1 Industry Growth and Trends Forecast to 2032

Report ID 173999860127 December 2025100 pages

Choose your research edition.

Industry ResearchHuman Immunodeficiency Virus Type-1 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Immunodeficiency Virus Type-1 Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Human Immunodeficiency Virus Type-1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Immunodeficiency Virus Type-1 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Immunodeficiency Virus Type-1 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

According to APO Research, the global Human Immunodeficiency Virus Type-1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Immunodeficiency Virus Type-1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Immunodeficiency Virus Type-1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Immunodeficiency Virus Type-1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Human Immunodeficiency Virus Type-1 market include AstraZeneca, Bayer, Bristol Myers Squibb, Merck & Co. Inc., Novartis, Pfizer, Viatris, GSK and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Immunodeficiency Virus Type-1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Immunodeficiency Virus Type-1 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Immunodeficiency Virus Type-1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Immunodeficiency Virus Type-1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Human Immunodeficiency Virus Type-1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Immunodeficiency Virus Type-1 Market by Company

AstraZeneca

Bayer

Bristol Myers Squibb

Merck & Co. Inc.

Novartis

Pfizer

Viatris

GSK

Roche

Sanofi

Human Immunodeficiency Virus Type-1 Segment by Type

Integrase Inhibitor

Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)

Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Protease Inhibitors (PIs)

Others

Human Immunodeficiency Virus Type-1 Segment by Application

Retail Pharmacies

Hospital Pharmacies

Human Immunodeficiency Virus Type-1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immunodeficiency Virus Type-1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Immunodeficiency Virus Type-1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immunodeficiency Virus Type-1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Human Immunodeficiency Virus Type-1 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Human Immunodeficiency Virus Type-1 Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Human Immunodeficiency Virus Type-1 Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2021-2026) Table 4. Global Human Immunodeficiency Virus Type-1 Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2027-2032) Table 6. Global Human Immunodeficiency Virus Type-1 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Human Immunodeficiency Virus Type-1 Market Size Share by Type (2021-2026) Table 9. Global Human Immunodeficiency Virus Type-1 Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Human Immunodeficiency Virus Type-1 Market Size Share Forecasted by Type (2027-2032) Table 11. North America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Human Immunodeficiency Virus Type-1 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Human Immunodeficiency Virus Type-1 Market Size Share by Application (2021-2026) Table 24. Global Human Immunodeficiency Virus Type-1 Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Human Immunodeficiency Virus Type-1 Market Size Share Forecasted by Application (2027-2032) Table 26. North America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Human Immunodeficiency Virus Type-1 Industry Trends Table 37. Human Immunodeficiency Virus Type-1 Industry Drivers Table 38. Human Immunodeficiency Virus Type-1 Industry Opportunities and Challenges Table 39. Human Immunodeficiency Virus Type-1 Industry Restraints Table 40. Global Human Immunodeficiency Virus Type-1 Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Company (2021-2026) Table 42. Global Human Immunodeficiency Virus Type-1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Human Immunodeficiency Virus Type-1 Key Company Headquarters & Area Served Table 44. Global Human Immunodeficiency Virus Type-1 Company, Product Type & Application Table 45. Global Human Immunodeficiency Virus Type-1 Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Human Immunodeficiency Virus Type-1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AstraZeneca Company Information Table 49. AstraZeneca Business Overview Table 50. AstraZeneca Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AstraZeneca Human Immunodeficiency Virus Type-1 Product Portfolio Table 52. AstraZeneca Recent Development Table 53. Bayer Company Information Table 54. Bayer Business Overview Table 55. Bayer Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Bayer Human Immunodeficiency Virus Type-1 Product Portfolio Table 57. Bayer Recent Development Table 58. Bristol Myers Squibb Company Information Table 59. Bristol Myers Squibb Business Overview Table 60. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product Portfolio Table 62. Bristol Myers Squibb Recent Development Table 63. Merck & Co. Inc. Company Information Table 64. Merck & Co. Inc. Business Overview Table 65. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product Portfolio Table 67. Merck & Co. Inc. Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Novartis Human Immunodeficiency Virus Type-1 Product Portfolio Table 72. Novartis Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pfizer Human Immunodeficiency Virus Type-1 Product Portfolio Table 77. Pfizer Recent Development Table 78. Viatris Company Information Table 79. Viatris Business Overview Table 80. Viatris Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Viatris Human Immunodeficiency Virus Type-1 Product Portfolio Table 82. Viatris Recent Development Table 83. GSK Company Information Table 84. GSK Business Overview Table 85. GSK Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. GSK Human Immunodeficiency Virus Type-1 Product Portfolio Table 87. GSK Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Roche Human Immunodeficiency Virus Type-1 Product Portfolio Table 92. Roche Recent Development Table 93. Sanofi Company Information Table 94. Sanofi Business Overview Table 95. Sanofi Human Immunodeficiency Virus Type-1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sanofi Human Immunodeficiency Virus Type-1 Product Portfolio Table 97. Sanofi Recent Development Table 98. North America Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2026) Table 101. North America Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Human Immunodeficiency Virus Type-1 Market Share Forecast by Country (2027-2032) Table 103. Europe Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2026) Table 106. Europe Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Human Immunodeficiency Virus Type-1 Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2026) Table 111. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Share Forecast by Country (2027-2032) Table 113. Latin America Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2026) Table 116. Latin America Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Human Immunodeficiency Virus Type-1 Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2026) Table 121. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Human Immunodeficiency Virus Type-1 Product Image Figure 3. Global Human Immunodeficiency Virus Type-1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 5. Global Human Immunodeficiency Virus Type-1 Market Share by Region: 2025 VS 2032 Figure 6. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2021-2032) Figure 7. North America Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Integrase Inhibitor Image Figure 13. Global Integrase Inhibitor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Image Figure 15. Global Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Image Figure 17. Global Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Protease Inhibitors (PIs) Image Figure 19. Global Protease Inhibitors (PIs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Human Immunodeficiency Virus Type-1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Human Immunodeficiency Virus Type-1 Market Share by Type 2025 VS 2032 Figure 24. North America Human Immunodeficiency Virus Type-1 Market Size Share by Type (2021-2032) Figure 25. Europe Human Immunodeficiency Virus Type-1 Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Share by Type (2021-2032) Figure 27. Latin America Human Immunodeficiency Virus Type-1 Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Human Immunodeficiency Virus Type-1 Market Size Share by Type (2021-2032) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Hospital Pharmacies Image Figure 32. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Human Immunodeficiency Virus Type-1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Human Immunodeficiency Virus Type-1 Market Share by Application 2025 VS 2032 Figure 35. North America Human Immunodeficiency Virus Type-1 Market Size Share by Application (2021-2032) Figure 36. Europe Human Immunodeficiency Virus Type-1 Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Share by Application (2021-2032) Figure 38. Latin America Human Immunodeficiency Virus Type-1 Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Human Immunodeficiency Virus Type-1 Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Human Immunodeficiency Virus Type-1 Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Human Immunodeficiency Virus Type-1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Human Immunodeficiency Virus Type-1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032) Figure 45. Europe Human Immunodeficiency Virus Type-1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Human Immunodeficiency Virus Type-1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032) Figure 48. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032) Figure 51. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Human Immunodeficiency Virus Type-1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032) Figure 54. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Integrase Inhibitor
  • Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
  • Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • Protease Inhibitors (PIs)
  • Others
Applications
  • Retail Pharmacies
  • Hospital Pharmacies
Companies covered
  • AstraZeneca
  • Bayer
  • Bristol Myers Squibb
  • Merck & Co. Inc.
  • Novartis
  • Pfizer
  • Viatris
  • GSK
  • Roche
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Human Immunodeficiency Virus Type-1 Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Human Immunodeficiency Virus Type-1 Market Size by Region (2021-2032)
  5. 1.4.1 Global Human Immunodeficiency Virus Type-1 Market Size by Region (2021-2026)
  6. 1.4.2 Global Human Immunodeficiency Virus Type-1 Market Size by Region (2027-2032)
  7. 1.5 Key Regions Human Immunodeficiency Virus Type-1 Market Size (2021-2032)
  8. 1.5.1 North America Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Growth Rate (2021-2032)
2 Human Immunodeficiency Virus Type-1 Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Integrase Inhibitor
  3. 2.1.2 Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
  4. 2.1.3 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  5. 2.1.4 Protease Inhibitors (PIs)
  6. 2.1.5 Others
  7. 2.2 Global Human Immunodeficiency Virus Type-1 Market Size by Type
  8. 2.2.1 Global Human Immunodeficiency Virus Type-1 Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Human Immunodeficiency Virus Type-1 Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Human Immunodeficiency Virus Type-1 Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Human Immunodeficiency Virus Type-1 Market Size by Regions
  12. 2.3.1 North America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Human Immunodeficiency Virus Type-1 Market Size Breakdown by Type (2021-2026)
3 Human Immunodeficiency Virus Type-1 Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Retail Pharmacies
  3. 3.1.2 Hospital Pharmacies
  4. 3.2 Global Human Immunodeficiency Virus Type-1 Market Size by Application
  5. 3.2.1 Global Human Immunodeficiency Virus Type-1 Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Human Immunodeficiency Virus Type-1 Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Human Immunodeficiency Virus Type-1 Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Human Immunodeficiency Virus Type-1 Market Size by Regions
  9. 3.3.1 North America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Human Immunodeficiency Virus Type-1 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Human Immunodeficiency Virus Type-1 Industry Trends
  2. 4.2 Human Immunodeficiency Virus Type-1 Industry Drivers
  3. 4.3 Human Immunodeficiency Virus Type-1 Industry Opportunities and Challenges
  4. 4.4 Human Immunodeficiency Virus Type-1 Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Human Immunodeficiency Virus Type-1 Revenue (2021-2026)
  2. 5.2 Global Human Immunodeficiency Virus Type-1 Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Human Immunodeficiency Virus Type-1 Key Company Headquarters & Area Served
  4. 5.4 Global Human Immunodeficiency Virus Type-1 Company, Product Type & Application
  5. 5.5 Global Human Immunodeficiency Virus Type-1 Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Human Immunodeficiency Virus Type-1 Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Human Immunodeficiency Virus Type-1 Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Human Immunodeficiency Virus Type-1 Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Human Immunodeficiency Virus Type-1 Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Human Immunodeficiency Virus Type-1 Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Bristol Myers Squibb
  14. 6.3.1 Bristol Myers Squibb Company Information
  15. 6.3.2 Bristol Myers Squibb Business Overview
  16. 6.3.3 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product Portfolio
  18. 6.3.5 Bristol Myers Squibb Recent Developments
  19. 6.4 Merck & Co. Inc.
  20. 6.4.1 Merck & Co. Inc. Company Information
  21. 6.4.2 Merck & Co. Inc. Business Overview
  22. 6.4.3 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product Portfolio
  24. 6.4.5 Merck & Co. Inc. Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Human Immunodeficiency Virus Type-1 Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Human Immunodeficiency Virus Type-1 Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Viatris
  38. 6.7.1 Viatris Company Information
  39. 6.7.2 Viatris Business Overview
  40. 6.7.3 Viatris Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Viatris Human Immunodeficiency Virus Type-1 Product Portfolio
  42. 6.7.5 Viatris Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 GSK Human Immunodeficiency Virus Type-1 Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Roche Human Immunodeficiency Virus Type-1 Product Portfolio
  54. 6.9.5 Roche Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Human Immunodeficiency Virus Type-1 Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Human Immunodeficiency Virus Type-1 Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
7 North America
  1. 7.1 North America Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026)
  3. 7.3 North America Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026)
  3. 8.3 Europe Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026)
  3. 10.3 South America Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst